Novo Nordisk Foundation
CHALLENGE PROGRAMME 2027 – Advancing Next Generation AMR Diagnostics for Lower Respiratory Tract Infections
2:00pm Copenhagen time
Last verified:
Details
| Funder | Novo Nordisk Foundation |
| Budget | DKK 30–75 million per grant |
| Deadline | 7 October 2026 |
| Consortium | Required — consortium of research partners with a clear vision and mission |
| Application | 2-stage: Stage 1 results December 2026, Stage 2 results June 2027 |
| Frequency | One-off |
| Eligible countries | DK |
Eligibility & scope
Funds leading researchers forming a consortium to develop innovative next-generation AMR diagnostics for lower respiratory tract infections. Open internationally; targets established research leaders/professors. Consortium required. Proposals must align with Novo Nordisk Foundation Strategy. Clinical/patient-sample relevance expected given infectious disease focus.
Related on Grantsby
- Novo Nordisk Foundation Challenge Programme — full programme guide
Eligibility, budget, success rates, application timeline, FAQ.
More from Novo Nordisk Foundation
Interdisciplinary Synergy Programme 2026
Deadline: 20 May 2026Up to DKK 19.4 million per grantNovo Nordisk Foundation Interdisciplinary Synergy Programme 2026
Deadline: 20 May 2026Up to DKK 19.4M (~€2.6M)Steno Collaborative Grants
Deadline: 2 Jun 2026DKK 1M–DKK 10M per grant (total pool up to DKK 30M)Non-Diabetic Endocrinology Collaborative Grants 2026
Deadline: 3 Jun 2026DKK 5M–10M per grant (total pool up to DKK 53M)Project grants in Endocrinology and Metabolism – Nordic Region
Deadline: 4 Jun 2026Up to DKK 4.5 million per grant
Does this grant match your research?
Sign up free to get a personalised match score and weekly alerts for grants like this.
Get started free